Global Cord Blood (NYSE:CO) is scheduled to be issuing its quarterly earnings data after the market closes on Tuesday, August 27th.
Global Cord Blood (NYSE:CO) last released its earnings results on Tuesday, June 18th. The medical research company reported $0.11 EPS for the quarter. Global Cord Blood had a return on equity of 8.84% and a net margin of 29.56%. The business had revenue of $37.50 million for the quarter.
Global Cord Blood stock traded up $0.04 during mid-day trading on Thursday, hitting $5.50. The company had a trading volume of 1,498 shares, compared to its average volume of 45,378. The stock’s 50 day moving average price is $5.65 and its two-hundred day moving average price is $6.44. Global Cord Blood has a 12 month low of $4.82 and a 12 month high of $7.73. The company has a market capitalization of $668.53 million, a PE ratio of 15.86 and a beta of 0.20.
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services.
Further Reading: How to Track your Portfolio in Google Finance
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.